SG Americas Securities, LLC
Broker-DealerPosition in CHRS — Coherus Oncology, Inc.
CIK 1313360
NEW YORK, NY
Position in CHRS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$44,837
-$10,589 QoQ
Shares Held
32,027
-2.3% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 145 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. CHRS ranks #162 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in CHRS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,837 | 32,027 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $55,426 | 32,797 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $48,899 | 34,436 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $19,588 | 11,944 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $52,726 | 65,336 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $65,656 | 47,577 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $44,191 | 42,492 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $213,788 | 123,577 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $41,884 | 17,525 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $243,669 | 73,174 | Shares | Sole | 2024-01-12 | |
| 2023-03-31 | $185,528 | 27,124 | Shares | Sole | 2023-04-28 | |
| 2022-06-30 | $514,532 | 71,068 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $566,684 | 43,895 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,264,654 | 79,239 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,385,234 | 86,200 | Shares | Sole | 2021-11-01 | |
| 2021-03-31 | $271,760 | 18,601 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $152,700 | 8,786 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $843,603 | 45,998 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $749,316 | 41,955 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $302,486 | 18,649 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||